U.S. Markets closed

Pressure BioSciences, Inc. (PBIO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.248-0.00 (-0.80%)
At close: 2:31PM EDT
People also watch
Interactive chart
Previous Close0.250
Bid0.000 x
Ask0.000 x
Day's Range0.223 - 0.260
52 Week Range0.150 - 0.500
Avg. Volume75,840
Market Cap8.14M
PE Ratio (TTM)-2.51
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017
    Capital Cube2 months ago

    Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017

    Categories: Yahoo Finance Get free summary analysis Pressure BioSciences, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Pressure BioSciences, Inc. – MOCON, Inc., PerkinElmer, Inc., Harvard Bioscience, Inc., Thermo Fisher Scientific Inc. and Bruker Corporation (MOCO-US, PKI-US, HBIO-US, TMO-US and BRKR-US) that have also reported ... Read more (Read more...)

  • Benzinga6 months ago

    Pressure Biosciences CEO On Biological Samples: It's All About How You Break Open A Cell

    “In a research lab, one of the most critical parts of scientific research is what we call sample preparation. It is absolutely critical that you are as good as you can be when you’re preparing the sample ...

  • Zacks Small Cap Research6 months ago

    PBIO: Update on Third Quarter Financials

    The company expects grant revenue to begin to increase in the fourth quarter of 2016 and continue to increase into 2017. Total revenue decreased to $535,334 in the third quarter 2016 from $580,334 for the third quarter of 2015. Adjusted net loss per common share was $(0.02) for the quarters ended September 30, 2016, compared to net loss per share of (0.03) for third quarter of 2015.